Methylcholanthrene and Sulindac share 10 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.313 means 31% of the combined target set is bound by both compounds. The IDF-weighted score of 0.242 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do Methylcholanthrene and Sulindac have in common?
Methylcholanthrene and Sulindac share 10 molecular targets with a Jaccard similarity of 31%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can Methylcholanthrene and Sulindac be combined?
Methylcholanthrene and Sulindac share 10 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: Methylcholanthrene or Sulindac?
Both Methylcholanthrene and Sulindac have substantial PubMed research. View their individual profiles for full evidence scores.